Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Phase i clinical trial of the immunocytokine emd 273063 in melanoma patients

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • King, D. M.
  • Albertini, M. R.
  • Schalch, H.
  • Hank, J. A.
  • Gan, J.
  • Surfus, J.
  • Mahvi, D.
  • Schiller, J. H.
  • Warner, T.
  • Kim, K.
  • Eickhoff, J.
  • Kendra, K.
  • Reisfeld, Ralph
  • Gillies, S. D.
  • Sondel, P.

publication date

  • November 2004

journal

  • Journal of Clinical Oncology  Journal

subject areas

  • Adult
  • Aged
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Female
  • Humans
  • Infusions, Intravenous
  • Interleukin-2
  • Male
  • Maximum Tolerated Dose
  • Melanoma
  • Middle Aged
  • Skin Neoplasms
  • Treatment Outcome
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2004.11.035

PubMed ID

  • 15483010
scroll to property group menus

Additional Document Info

start page

  • 4463

end page

  • 4473

volume

  • 22

issue

  • 22

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support